Footmaxx, Inc. is a leading player in the Medical Devices industry, specializing in the production and global marketing of high-quality, state-of-the-art orthopedic devices and products. The company's proprietary software empowers clinicians to evaluate patients for various musculoskeletal and biomechanical issues, including balance, knee, hip, lower back problems. In particular, the 3Dmaxx scanner stands out with its ability to capture up to 800,000 data points in as fast as 8 seconds, offering three casting options to cater to different patient needs.
Footmaxx also offers the Metascan pressure mat, which captures dynamic function and utilizes diagnostic software to analyze data, translating it into customized orthotics prescriptions. The company's presence in the United States and Canada, along with its international distribution partnerships, positions it as a significant player in the global market.
Catering to a wide range of medical professionals, including Orthopedic Surgeons, Physiotherapists, Chiropractors, and Podiatrists, Footmaxx's products are utilized for assessing, diagnosing, and treating various patient conditions. The company's proprietary diagnostics play a fundamental role in uncovering, confirming, and tracking the progress of treatment regimens.
Founded in 1994, Footmaxx, Inc. remains at the forefront of the industry, offering innovative solutions aimed at improving patient function and correcting injuries. With a strong product portfolio and established market presence, the company presents an attractive opportunity for venture capital investment in the rapidly evolving medical devices sector.
There is no investment information
No recent news or press coverage available for Footmaxx, Inc..